Source: BioSpace

Kayentis: Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector

Kayentis, a global provider of eCOA solutions for clinical trials, announces the opening of a subsidiary in Japan, the world's third largest pharmaceutical market, where clinical developments have been expanding.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Guillaume Juge's photo - President & CEO of Kayentis

President & CEO

Guillaume Juge

CEO Approval Rating

73/100

Read more